Free Trial

ALX Oncology (ALXO) Earnings Date, Estimates & Call Transcripts

ALX Oncology logo
$0.55 +0.04 (+8.76%)
Closing price 04/15/2025 04:00 PM Eastern
Extended Trading
$0.54 -0.01 (-1.87%)
As of 04/15/2025 07:56 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

ALX Oncology Earnings Summary

Upcoming Q3
Earnings Date
May. 8Before Market OpensEstimated
Consensus EPS
(Aug. 8)
-$0.77
Actual EPS
(Aug. 8)
-$0.76 Beat By $0.01

ALX Oncology posted Q2 2024 earnings on August 8, 2024, reporting an EPS of -$0.76, which topped the consensus estimate of -$0.77 by $0.01. With a trailing EPS of -$2.60, ALX Oncology's earnings are expected to grow next year, from ($2.76) to ($2.50) per share.

Q2 2024 Earnings Resources

ALXO Upcoming Earnings

ALX Oncology's Q1 2025 earnings is scheduled for Thursday, May 8, 2025, with a conference call scheduled at 3:00 AM ET. Check back for transcripts, audio, and key financial metrics as they become available.

Get ALX Oncology Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on ALX Oncology and other key companies, straight to your inbox.

Sign Up
Skip Charts & View Estimated and Actual Earnings Data

ALXO Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.
Remove Ads

ALX Oncology Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20251-$0.61-$0.61-$0.61
Q2 20251-$0.66-$0.66-$0.66
Q3 20251-$0.68-$0.68-$0.68
Q4 20251-$0.61-$0.61-$0.61
FY 20254($2.56)($2.56)($2.56)
Remove Ads

ALX Oncology Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
5/8/2025
(Estimated)
-------
8/8/2024--$0.77-$0.76+$0.01-$0.76--
5/9/2024Q1 2024-$0.87-$0.71+$0.16-$0.71--
3/7/2024Q4 2023-$0.84-$0.93 -$0.09-$0.93--
11/13/2023Q3 2023-$0.86-$1.24 -$0.38-$1.24--
8/10/2023Q2 2023-$0.85-$0.84+$0.01-$0.84--
5/11/2023Q1 2023-$0.84-$0.58+$0.26-$0.42--

ALX Oncology Earnings - Frequently Asked Questions

ALX Oncology has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, May 8th, 2025 based off last year's report dates. Learn more on ALXO's earnings history.

In the previous quarter, ALX Oncology (NASDAQ:ALXO) reported ($0.76) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.77) by $0.01. Learn more on analysts' earnings estimate vs. ALXO's actual earnings.

ALX Oncology (NASDAQ:ALXO) has a recorded net income of -$160.80 million. ALXO has generated -$2.60 earnings per share over the last four quarters.

ALX Oncology's earnings are expected to grow from ($2.76) per share to ($2.50) per share in the next year.

More Earnings Resources from MarketBeat

Remove Ads


This page (NASDAQ:ALXO) was last updated on 4/16/2025 by MarketBeat.com Staff
From Our Partners